+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medicated Skin Care Products - Global Market Trajectory & Analytics

  • ID: 338929
  • Report
  • June 2020
  • Region: Global
  • 216 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Bayer AG (Germany)
  • EltaMD, Inc. (USA)
  • Johnson & Johnson (USA)
  • NEOCUTIS (USA)
  • Prestige Brands (USA)
  • SkinMedica, Inc. (USA)
  • MORE
Amid the COVID-19 crisis and the looming economic recession, the Medicated Skin Care Products market worldwide will grow by a projected US$1.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 2.1%. Medicated Skin Care Products, one of the segments analyzed and sized in this study, is forecast to grow at over 2.1% and reach a market size of US$8.1 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Medicated Skin Care Products market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 1.2% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$23.2 Million to the region's size over the next 7 to 8 years. In addition, over US$27.9 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Medicated Skin Care Products segment will reach a market size of US$481.8 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Medicated Skin Care Products market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 4.5% over the next couple of years and add approximately US$394.5 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Medicated Skin Care Products market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,
  • Advanced Dermatology Corp.
  • Bayer AG
  • Beiersdorf AG
  • Chattem Inc.
  • EltaMD Inc.
  • Episciences Inc.
  • Galderma S.A.
  • GlaxoSmithKline Plc
  • IntraDerm™ Pharmaceuticals
  • Johnson & Johnson
  • Kao Corporation
  • La Prairie Group AG
  • Laboratorios Leti SL
  • L`Oréal S.A.
  • Medimetriks Pharmaceuticals Inc.
  • Merz Pharma GmbH & Co. KGaA
  • NEOCUTIS
  • Obagi Medical Products Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • PCA Skin
  • Pfizer Inc.
  • Shiseido Co. Ltd.
  • SkinCeuticals
  • SkinMedica Inc.
  • Skinvisible Pharmaceuticals Inc.
  • Stiefel Laboratories Inc.
  • Taisho Pharmaceuticals Co. Ltd.
  • The Himalaya Drug Company
  • Unilever NV
  • Valeant Pharmaceuticals International Inc.
  • Vivier Pharma
  • ZO® Skin Health Inc.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG (Germany)
  • EltaMD, Inc. (USA)
  • Johnson & Johnson (USA)
  • NEOCUTIS (USA)
  • Prestige Brands (USA)
  • SkinMedica, Inc. (USA)
  • MORE
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Medicated Skin Care Products: Medical Solutions for Skin Health Needs
Recent Market Activity
Convergence of Beauty and Healthcare
Growth Drivers in a Nutshell
Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver
Major Skin Diseases: Few Fast Facts
Global Market Outlook
Developed Markets: Traditional Revenue Contributors
Developing Countries Continue to Offer Significant Growth Opportunities
Competitive Scenario
Leading Players in the Global Medicated Skin Care Products Market
Vendors Emphasize Collaborations
M&A Activity
Select M&A Deals in the Global Medicated Skin Care Products Market in the Recent Past
Global Competitor Market Shares
Medicated Skin Care Products Competitor Market Share Scenario Worldwide (in %): 2019E
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Advanced Dermatology Corporation (USA)
Bayer AG (Germany)
Beiersdorf AG (Germany)
La Prairie Group AG (Switzerland)
Chattem, Inc. (USA)
Curatio Healthcare India Pvt. Ltd. (India)
Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany)
EltaMD, Inc. (USA)
Episciences, Inc. (USA)
Galderma S.A. (Switzerland)
GlaxoSmithKline Plc (UK)
Stiefel Laboratories Inc. (USA)
IntraDerm™ Pharmaceuticals (USA)
Johnson & Johnson (USA)
Kao Corporation (Japan)
Laboratorios Leti SL. (Spain)
L'Oréal S.A. (France)
Medimetriks Pharmaceuticals, Inc. (USA)
Merz Pharma GmbH & Co. KGaA (Germany)
NEOCUTIS (USA)
Otsuka Pharmaceutical Co., Ltd. (Japan)
PCA Skin (USA)
Pfizer Inc. (USA)
Prestige Brands (USA)
Shiseido Co., Ltd. (Japan)
RéVive Skincare (USA)
SkinCeuticals (USA)
SkinMedica, Inc. (USA)
Skinvisible Pharmaceuticals, Inc. (USA)
Taisho Pharmaceuticals Co., Ltd. (Japan)
The Himalaya Drug Company (India)
Unilever NV (Netherlands)
Valeant Pharmaceuticals International, Inc. (Canada)
Obagi Medical Products, Inc. (USA)
Vivier Pharma (Canada)
ZO® Skin Health Inc. (USA)

3. MARKET TRENDS & DRIVERS
Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
Health & Wellness Boosts Demand for Dermocosmetics
Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
Major Anti-Aging Ingredients of Cosmeceuticals
Popular Cosmeceutical Contents
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market
Common Skin Care Cosmeceuticals
Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions
Medicated Skin Care Innovations: Spearheading Growth
Innovations for Acne
Innovations for Actinic Keratosis
Innovations for Tuberous Sclerosis Complex and Angiofibromas
Melasma Treatment Innovations
Onychomycosis Treatment Innovations
Innovations for Alopecia/Hair Loss
Stem Cell Technology: The New Frontier?
Intelligent Scanning for Identifying Beneficial Ingredients
Innovations in Anti-Aging Skin Care
Other Noteworthy Medicated Skin Care Innovations
Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
What’s Next in Ingredients?
Innovative Ingredients Gain Focus
Aesthetic Dermatology to Witness Sustained Growth
Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market
Surging Popularity of Multi-Functional Products Promote Market Expansion
Sales of Hydroquinone-free Products Gain Momentum
Facial Wipes Offers Huge Untapped Growth Potential
Women: The Dominant Consumer Cluster for Medicated Skin Care Products
Physiological Differences Entail Need for Male Specific Products
Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
Increasing Environmental Pollution Drive Demand for Anti-Pollution Skin Care Products
Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Medicated Skin Care Products Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Medicated Skin Care Products Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Medicated Skin Care Products Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
Market Analytics
TABLE 4: United States Medicated Skin Care Products Market Estimates and Projections in US$ Million: 2020 to 2027
TABLE 5: Medicated Skin Care Products Market in the United States: A Historic Review in US$ Million for 2012-2019
CANADA
TABLE 6: Canadian Medicated Skin Care Products Market Estimates and Forecasts in US$ Million: 2020 to 2027
TABLE 7: Canadian Medicated Skin Care Products Historic Market Review in US$ Million: 2012-2019
JAPAN
TABLE 8: Japanese Market for Medicated Skin Care Products: Annual Sales Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 9: Medicated Skin Care Products Market in Japan: Historic Sales Analysis in US$ Million for the Period 2012-2019
CHINA
TABLE 10: Chinese Medicated Skin Care Products Market Growth Prospects in US$ Million for the Period 2020-2027
TABLE 11: Medicated Skin Care Products Historic Market Analysis in China in US$ Million: 2012-2019
EUROPE
Market Facts & Figures
Market Analytics
TABLE 12: European Medicated Skin Care Products Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 13: Medicated Skin Care Products Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 14: European Medicated Skin Care Products Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
FRANCE
TABLE 15: Medicated Skin Care Products Market in France: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 16: French Medicated Skin Care Products Historic Market Scenario in US$ Million: 2012-2019
GERMANY
TABLE 17: Medicated Skin Care Products Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2020-2027
TABLE 18: German Medicated Skin Care Products Historic Market Analysis in US$ Million: 2012-2019
ITALY
TABLE 19: Italian Medicated Skin Care Products Market Growth Prospects in US$ Million for the Period 2020-2027
TABLE 20: Medicated Skin Care Products Historic Market Analysis in Italy in US$ Million: 2012-2019
UNITED KINGDOM
TABLE 21: United Kingdom Market for Medicated Skin Care Products: Annual Sales Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 22: Medicated Skin Care Products Market in the United Kingdom: Historic Sales Analysis in US$ Million for the Period 2012-2019
SPAIN
TABLE 23: Spanish Medicated Skin Care Products Market Estimates and Forecasts in US$ Million: 2020 to 2027
TABLE 24: Spanish Medicated Skin Care Products Historic Market Review in US$ Million: 2012-2019
RUSSIA
TABLE 25: Russian Medicated Skin Care Products Market Estimates and Projections in US$ Million: 2020 to 2027
TABLE 26: Medicated Skin Care Products Market in Russia: A Historic Review in US$ Million for 2012-2019
REST OF EUROPE
TABLE 27: Rest of Europe Medicated Skin Care Products Market Estimates and Forecasts in US$ Million: 2020-2027
TABLE 28: Medicated Skin Care Products Market in Rest of Europe in US$ Million: A Historic Review for the Period 2012-2019
ASIA-PACIFIC
TABLE 29: Asia-Pacific Medicated Skin Care Products Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 30: Medicated Skin Care Products Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 31: Asia-Pacific Medicated Skin Care Products Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
AUSTRALIA
TABLE 32: Medicated Skin Care Products Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2020-2027
TABLE 33: Australian Medicated Skin Care Products Historic Market Analysis in US$ Million: 2012-2019
INDIA
TABLE 34: Indian Medicated Skin Care Products Market Estimates and Forecasts in US$ Million: 2020 to 2027
TABLE 35: Indian Medicated Skin Care Products Historic Market Review in US$ Million: 2012-2019
SOUTH KOREA
TABLE 36: Medicated Skin Care Products Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2020-2027
TABLE 37: South Korean Medicated Skin Care Products Historic Market Analysis in US$ Million: 2012-2019
REST OF ASIA-PACIFIC
TABLE 38: Rest of Asia-Pacific Market for Medicated Skin Care Products: Annual Sales Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 39: Medicated Skin Care Products Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million for the Period 2012-2019
LATIN AMERICA
TABLE 40: Latin American Medicated Skin Care Products Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 41: Medicated Skin Care Products Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 42: Latin American Medicated Skin Care Products Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
ARGENTINA
TABLE 43: Argentinean Medicated Skin Care Products Market Estimates and Forecasts in US$ Million: 2020-2027
TABLE 44: Medicated Skin Care Products Market in Argentina in US$ Million: A Historic Review for the Period 2012-2019
BRAZIL
TABLE 45: Medicated Skin Care Products Market in Brazil: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 46: Brazilian Medicated Skin Care Products Historic Market Scenario in US$ Million: 2012-2019
MEXICO
TABLE 47: Medicated Skin Care Products Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2020-2027
TABLE 48: Mexican Medicated Skin Care Products Historic Market Analysis in US$ Million: 2012-2019
REST OF LATIN AMERICA
TABLE 49: Rest of Latin America Medicated Skin Care Products Market Estimates and Projections in US$ Million: 2020 to 2027
TABLE 50: Medicated Skin Care Products Market in Rest of Latin America: A Historic Review in US$ Million for 2012-2019
MIDDLE EAST
TABLE 51: The Middle East Medicated Skin Care Products Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 52: Medicated Skin Care Products Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 53: The Middle East Medicated Skin Care Products Market Share Breakdown by Region/Country: 2012, 2020, and 2027
IRAN
TABLE 54: Iranian Market for Medicated Skin Care Products: Annual Sales Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 55: Medicated Skin Care Products Market in Iran: Historic Sales Analysis in US$ Million for the Period 2012-2019
ISRAEL
TABLE 56: Israeli Medicated Skin Care Products Market Estimates and Forecasts in US$ Million: 2020-2027
TABLE 57: Medicated Skin Care Products Market in Israel in US$ Million: A Historic Review for the Period 2012-2019
SAUDI ARABIA
TABLE 58: Saudi Arabian Medicated Skin Care Products Market Growth Prospects in US$ Million for the Period 2020-2027
TABLE 59: Medicated Skin Care Products Historic Market Analysis in Saudi Arabia in US$ Million: 2012-2019
UNITED ARAB EMIRATES
TABLE 60: Medicated Skin Care Products Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2020-2027
TABLE 61: United Arab Emirates Medicated Skin Care Products Historic Market Analysis in US$ Million: 2012-2019
REST OF MIDDLE EAST
TABLE 62: Medicated Skin Care Products Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2020-2027
TABLE 63: Rest of Middle East Medicated Skin Care Products Historic Market Analysis in US$ Million: 2012-2019
AFRICA
TABLE 64: African Medicated Skin Care Products Market Estimates and Projections in US$ Million: 2020 to 2027
TABLE 65: Medicated Skin Care Products Market in Africa: A Historic Review in US$ Million for 2012-2019

IV. COMPETITION
Total Companies Profiled: 120
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Advanced Dermatology Corporation (USA)
  • Bayer AG (Germany)
  • Beiersdorf AG (Germany)
  • La Prairie Group AG (Switzerland)
  • Chattem, Inc. (USA)
  • Curatio Healthcare India Pvt. Ltd. (India)
  • Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany)
  • EltaMD, Inc. (USA)
  • Episciences, Inc. (USA)
  • Galderma S.A. (Switzerland)
  • GlaxoSmithKline Plc (UK)
  • Stiefel Laboratories Inc. (USA)
  • IntraDerm™ Pharmaceuticals (USA)
  • Johnson & Johnson (USA)
  • Kao Corporation (Japan)
  • Laboratorios Leti SL. (Spain)
  • L'Oréal S.A. (France)
  • Medimetriks Pharmaceuticals, Inc. (USA)
  • Merz Pharma GmbH & Co. KGaA (Germany)
  • NEOCUTIS (USA)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • PCA Skin (USA)
  • Pfizer Inc. (USA)
  • Prestige Brands (USA)
  • Shiseido Co., Ltd. (Japan)
  • RéVive Skincare (USA)
  • SkinCeuticals (USA)
  • SkinMedica, Inc. (USA)
  • Skinvisible Pharmaceuticals, Inc. (USA)
  • Taisho Pharmaceuticals Co., Ltd. (Japan)
  • The Himalaya Drug Company (India)
  • Unilever NV (Netherlands)
  • Valeant Pharmaceuticals International, Inc. (Canada)
  • Obagi Medical Products, Inc. (USA)
  • Vivier Pharma (Canada)
  • ZO® Skin Health Inc. (USA)
Note: Product cover images may vary from those shown
Adroll
adroll